|
|
Do "Subject handouts" for clinical trials have to be submitted to the FHREB?
Answer
Written information, which is entirely trial specific and MUST be supplied to the subject for them to be on the trial (not just for their treatment) must be approved by the FHREB. Information that is supplied to patients, whether they are on the trial or not or for standard treatments given during trials do not require FHREB review. For example, in an immunization trial all subjects may receive standard chemotherapy prior to the experimental immunization. The standard chemotherapy regimen is used for both trial subjects and patients not on a trial. There is no need for FHREB review of the standard chemotherapy handouts that are given to the subject. Or, for example, a general pamphlet describing vaccine treatment prepared by the company for any individual interested in the topic whether they are a patient or not or whether they will be a subject on the trial or not, does not need approval. However, if a subject could not be on the trial without receiving a document, for example, a required questionnaire, that document must be approved.
|